Your Safety is Our Top Priority

As planning is underway for the ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines, your health and safety are ASM’s utmost priority. ASM is actively evaluating conditions and developing meeting policies to ensure a safe environment for all participants traveling to Baltimore.

Because of the COVID-19 pandemic, local conditions and safety guidelines are constantly evolving. We are closely monitoring the current state, federal and local COVID-19 guidelines for in-person gatherings and travel restrictions as conditions change between now and Oct. 2022.

ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines Health & Safety Policies

vaccine icon
Vaccination Required

All participants must provide proof of full COVID-19 vaccination to be issued credentials to attend the ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines. Participants must be fully vaccinated with a vaccine approved by the U.S. Food and Drug Administration (FDA) or World Health Organization (WHO). Following current Center for Disease Control and Prevention (CDC) guidelines, a person is considered fully vaccinated if they satisfy either of the following criteria: 

  • 2 weeks have passed since their second dose in a 2-dose series, such as the Pfizer and Moderna vaccines. 
  • 2 weeks have passed since receiving a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine. 

Additionally, COVID-19 vaccines authorized for emergency use by the World Health Organization (i.e., AstraZeneca/Oxford, Covishield, Sinopharm and Sinovac), on or before Oct. 1, 2022 are approved for attendance to ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines. Please refer to the list of approved vaccines with WHO EUL/PQ evaluation status.  

ASM strongly encourages all attendees take a COVID-19 test prior to departing to Baltimore and follow all guidelines set forth by the CDC for travel. Details on the vaccination verification process will be provided in August 2022.

Requirements for entry to the ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines are subject to change at any time based on governmental, venue or other mandates applicable to the meeting.

attestation icon
Health Attestation Prior to Attending 

Prior to entering ASM Conference on Rapid Applied Microbial Next-Generation Sequencing and Bioinformatic Pipelines meeting venue, participants must attest they have not:  
  • Been diagnosed with or tested positive for COVID-19 within the past 10 days. 
  • Been directed to self-isolate by a public health authority or healthcare provider due to potential exposure to COVID-19 within the past 10 days. 
  • Had any symptoms associated with COVID-19 infection, nor had any symptoms in the past 10 days, including fever of over 100.0; cough (not attributed to a pre-existing condition); shortness of breath or difficulty breathing; fatigue; muscle or body aches; loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; and/or diarrhea.
  • Had close contact (within 6 feet) with anyone under known quarantine or diagnosed with COVID-19 or showing systems of COVID-19 in the past 10 days. 

Meeting Venue Safety Initiatives

COVID-19 Clean Hotel Protocols

As a Marriott property, the Sheraton Inner Harbor Hotel has instituted enhanced safety and cleanliness standards. Learn more about the programs the Marriott has introduced at its hotel brands to ensure guests enjoy a clean and safe stay.

Sheraton Inner Harbor Hotel: COVID-19 updates and what to expect at Marriott hotels.
 

Twitter Feed #ASMNGS